Sofi Isaksson

Suggest Changes
Learn More
PURPOSE In lung adenocarcinoma, EGFR and KRAS mutations dominate the mutational spectrum and have clear therapeutic implications. We sought to determine whether transcriptional subgroups of clinical(More)
  • 1